Niche DMSO Clinic Camelot Cancer Care operates as one of a very small number of DMSO clinics in the United States, highlighting a highly specialized treatment offering that could appeal to patients seeking alternative or adjunctive therapies.

Large Revenue in Niche Reported annual revenue in the broad range of $100M–$1B suggests substantial scale for a medical practice with 11–50 employees, indicating potential capacity for partnerships, service expansions, or referral arrangements.

Affiliation & Referrals As a dedicated cancer care provider, Camelot may be a strategic partner for referral networks, clinical trial collaborations, or co-marketing with larger cancer centers seeking complementary therapy options.

Evidence & Trust Signals The emphasis on pharmaceutical-grade DMSO, testimonials, and Get A Second Opinion forms points to a patient-centric approach that can be leveraged in outreach to patients seeking alternative treatment pathways.

Growth Opportunities With a relatively small team size yet high revenue potential, there is room to scale through expanded service lines, telemedicine consultations, or partnerships with larger oncology networks to broaden patient access and generate increased referrals.